All In Biotech

Drug Trial Radar · NCT06003426

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Last checked: Nov 19, 2026Latest source record: Mar 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 1,255 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,255

Actual

Start

Sep 14, 2023

Primary completion

Oct 6, 2026

Study completion Jun 4, 2027

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Aug 22, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in participants with Idiopathic Pulmonary Fibrosis.

Conditions

  • Idiopathic Pulmonary Fibrosis

Interventions

  • BMS-986278Drug

    Specified dose on specified days

  • BMS-986278 PlaceboDrug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants that experience spontaneous syncopal eventsTime frame: At approximately 4 weeks
  2. Absolute change from baseline in forced vital capacity (FVC) measured in mLTime frame: Up to Week 52

Locations

390 sites in 33 countries. Site status is shown where the registry gives one.

  • Local Institution - 0189

    Birmingham, Alabama

  • Local Institution - 0361

    Phoenix, Arizona

  • Local Institution - 0396

    La Jolla, California

  • Local Institution - 0193

    Los Angeles, California

  • Local Institution - 0398

    Los Angeles, California

  • Local Institution - 0389

    Orange, California

  • Local Institution - 0405

    Sacramento, California

  • Local Institution - 0185

    San Francisco, California

  • Local Institution - 0186

    Stanford, California

  • Local Institution - 0363

    Aurora, Colorado

  • Local Institution - 0194

    Denver, Colorado

  • Local Institution - 0175

    New Haven, Connecticut

  • Local Institution - 0151

    Newark, Delaware

  • Local Institution - 0367

    Washington D.C., District of Columbia

  • Local Institution - 0101

    Brandon, Florida

  • Local Institution - 0436

    Clearwater, Florida

  • Local Institution - 0425

    DeBary, Florida

  • Local Institution - 0079

    Gainesville, Florida

  • Local Institution - 0352

    Hialeah, Florida

  • Local Institution - 0370

    Kissimmee, Florida

  • Local Institution - 0502

    Leesburg, Florida

  • Local Institution - 0153

    Loxahatchee Groves, Florida

  • Local Institution - 0187

    Ocala, Florida

  • Local Institution - 0418

    Pensacola, Florida

  • Local Institution - 0206

    St. Petersburg, Florida

  • Local Institution - 0364

    Tampa, Florida

  • Local Institution - 0372

    Dublin, Georgia

  • Local Institution - 0178

    Chicago, Illinois

  • Local Institution - 0183

    Chicago, Illinois

  • Local Institution - 0058

    Chicago, Illinois

  • Local Institution - 0085

    Maywood, Illinois

  • Local Institution - 0325

    Peoria, Illinois

  • Local Institution - 0180

    Iowa City, Iowa

  • Local Institution - 0204

    Kansas City, Kansas

  • Local Institution - 0393

    Louisville, Kentucky

  • Local Institution - 0354

    Baltimore, Maryland

  • Local Institution - 0380

    Boston, Massachusetts

  • Local Institution - 0040

    Boston, Massachusetts

  • Local Institution - 0472

    Ann Arbor, Michigan

  • Local Institution - 0096

    Chesterfield, Missouri

Showing 40 of 390 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.